GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Vision loss, thyroid tumours, kidney problems, gallbladder issues and pancreatitis are some of the concerning side effects ...

A new study raises mental health concerns about popular weight loss drugs like Ozempic and Mounjaro. These GLP-1 agonists, ...

Not everyone with ADHD responds to stimulants like Ritalin, which increase dopamine levels in the brain. Now, new research ...

Initially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster ...

A study shed light on the side effects of mental health, narrowing down those who are genetically more vulnerable.

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

OPC-14597 has been reported to produce minimal increases in D 2 receptor density following ... accumulation induced by dopamine, cAMP synthesis was stimulated with 1 μM isoproterenol, and the ...

New study finds potential link between GLP1 agonists and depression, urging further investigation into patient safety.